UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 8, 2022 (
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
(State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
(Address of principal executive offices) |
|
(Zip Code) |
(
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On July 2, 2022, Tivity Health, Inc. (the “Company”) entered into a Separation and Consulting Agreement and General Release (the “Separation Agreement”) with Adam Holland, Chief Financial Officer of the Company, which provided for the termination of Mr. Holland’s employment with the Company. The Separation Agreement also provides that Mr. Holland will receive those separation payments and benefits that he is entitled to receive under his employment agreement in respect of a termination without cause, which agreement has previously been disclosed. Mr. Holland will provide consulting services to the Company for a period of 30 days in order to facilitate the transition to his successor and will receive a consulting fee of $36,500 for providing such consulting services.
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 8, 2022
|
|
|
|
|
TIVITY HEALTH, INC. |
||
|
|
|
|
|
By: |
|
/s/ J. Raymond Bilbao |
|
Name: |
|
J. Raymond Bilbao |
|
Title: |
|
Chief Legal Officer and Corporate Secretary |
Document and Entity Information |
Jul. 02, 2022 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jul. 02, 2022 |
| Entity Registrant Name | TIVITY HEALTH, INC. |
| Entity Central Index Key | 0000704415 |
| Entity Emerging Growth Company | false |
| Entity File Number | 000-19364 |
| Entity Incorporation State Country Code | DE |
| Entity Tax Identification Number | 62-1117144 |
| Entity Address, Address Line One | 701 Cool Springs Boulevard |
| Entity Address, City or Town | Franklin |
| Entity Address, State or Province | TN |
| Entity Address, Postal Zip Code | 37067 |
| City Area Code | 800 |
| Local Phone Number | 869-5311 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |